2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Angina Market?

The upward trend in coronary artery disease cases is anticipated to fuel the growth of the angina market. Coronary artery disease (CAD), often called coronary heart disease (CHD) or ischemic heart disease (IHD), is a health condition defined by the narrowing or blockage of the coronary arteries responsible for supplying blood, oxygen, and nutrients to the heart muscle. This increase in CAD is attributed to lifestyle modifications as well as environmental and genetic factors. Angina serves as a crucial factor in detecting and acknowledging the prevalence of coronary artery disease. The appearance of angina triggers medical assessment and diagnosis, assists in risk stratification, aids in making treatment choices, and shapes public health policies. For example, the American Heart Association noted in January 2023 that the number of adults in the US living with CAD increased from 18.2 million to roughly 19.3 million between 2021 and 2022. Consequently, the growing occurrences of coronary artery diseases are propelling the angina market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

How Will the Growth Rate of theAngina Market Impact Industry Trends by 2034?

The market size for angina has seen a robust growth in the past few years. It’s expected to swell from $10.71 billion in 2024 to $11.4 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.4%. The significant growth in the previous years is due to higher incidence rates of coronary heart disease, more frequent use of vasodilators, a rise in myocardial ischemia prevalence, enhanced diagnostic methodologies, and an uptick in the employment of imaging techniques.

In the coming years, robust growth is anticipated in the angina market, reaching $14.44 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. The growth during the projected period can be credited to factors such as the escalating incidence of chronic angina pectoris, an increase in drug approvals and clinical studies, and a surging demand for retail pharmacies. Also driving the market’s growth are increasing recognition of cardiovascular health and an expanding demand for medications. Key trends in the projected period encompass innovation in early detection, progress in angioplasty and stenting procedures, the emergence of new gene therapy methods, a rising demand for coronary stents, and breakthroughs in treatments for coronary artery diseases.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

What Are the Most Significant Market Trends Transforming theAngina Market?

Leading enterprises in the angina market are focusing on creating innovative pharmaceuticals such as metoprolol tartrate tablets, aiming to offer improved, tailor-made remedies for individuals suffering from coronary artery disease (CAD) and similar issues. Metoprolol tartrate tablets are often prescribed for a range of cardiovascular diseases, including angina (chest discomfort), hypertension (elevated blood pressure), and heart failure. For example, Zydus, a pharmaceutical corporation based in India, secured the final consent from the United States Food and Drug Administration (US-FDA) in April 2023. This approval allows Zydus to produce and distribute its generic Metoprolol Tartrate Tablets USP in concentrations of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is utilized for treating numerous cardiovascular complications, including elevated blood pressure (hypertension) and chest discomfort (angina), and to enhance life expectancy post-heart attack.

What Are the Top Market Players Propelling the Growth of theAngina Industry?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Primary Segments of the Angina Market Are Driving Growth and Industry Transformations?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Angina Market?# Market?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Angina Market 2025, By The Business Research Company:

Medical Device Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-device-security-global-market-report

Generative AI In Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Egg Freezing And Embryo Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/egg-freezing-and-embryo-banking-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: